🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Healthcare Sector SEC Filings — July 22, 2026

The sole filing in this digest, an 8-K from Becton Dickinson & Co (BD), reports the retirement of a key executive, Dr. Michael Garrison, EVP and President of Medical Essentials and BioPharma Systems, effective October 2, 2026. While the event itself carries low materiality (3/10) and neutral sentiment, the structural change—placing BioPharma Systems directly under CEO Tom Polen—signals the company's strategic prioritization of this high-growth segment. This leadership transition creates a period of organizational uncertainty, particularly for the Medical Essentials division, which will require a new president. The lack of financial guidance or operational metrics in the filing limits the depth of quantitative trend analysis, but the move provides a qualitative insight into BD's strategic focus on its BioPharma Systems business as a key growth driver. No other filings were available for this period, preventing cross-company or sector-wide comparisons.

1 high priority 1 total filings
· daily

US Earnings Financial Results SEC Filings — July 22, 2026

This earnings digest reveals a sharply bifurcated market. On one side, industrial and infrastructure giants like GE Vernova, CSX, and United Rentals are delivering double-digit revenue and earnings growth, fueled by robust demand and pricing power. On the other, a cluster of micro-cap and pre-revenue companies (Star Gold, NaturalShrimp, Alzamend Neuro, Ankam) are burning cash and facing existential liquidity crises, with one (NaturalShrimp) adopting liquidation accounting. A notable theme is the 'growth at a cost' pattern: several companies (Wabtec, AT&T, Essential Properties) are reporting strong top-line growth but seeing net income or cash flow pressured by aggressive M&A, share buybacks, or rising interest expenses. The real estate sector (EastGroup, Essential Properties, NETSTREIT) shows strong operational momentum but is increasingly exposed to credit quality deterioration and higher financing costs. Insider activity was notably absent from the enriched data, but capital allocation decisions—particularly the aggressive share repurchases by AT&T and United Rentals—signal management confidence, while the surge in provisions for credit losses at Travel + Leisure and Essential Properties warrants caution. The overall picture is one of a resilient economy for large-cap industrials and select REITs, but a punishing environment for cash-burning small caps and companies with high leverage.

25 high priority 25 total filings
· daily

US IPO Pipeline SEC S-1 Filings — July 22, 2026

The IPO pipeline for July 22, 2026, features two blank-check companies (SPACs) and one de-SPAC merger filing, indicating continued SPAC activity despite regulatory scrutiny. NorthStrive Acquisition Corp I and Pinnacle Acquisition Corp both filed S-1 registrations, targeting $100 million and an undisclosed amount, respectively, with no identified targets. Air Industries Group filed an S-4 for its merger with Tenax Aerospace, a deal that would dilute existing AIRI shareholders to ~4% ownership. No period-over-period trends or insider activity are available as these are initial filings. The SPACs carry high execution risk, while the AIRI merger presents a high-risk, high-reward opportunity with significant dilution. The lack of forward-looking guidance or insider transactions limits actionable insights, but the filings signal ongoing appetite for SPAC vehicles and aerospace consolidation.

3 high priority 3 total filings
· daily

US SEC Trading Suspension Halt Orders — July 22, 2026

Both SunPower Inc. and Purple Innovation, Inc. have received Nasdaq notices regarding non-compliance with the minimum $1.00 bid price requirement, highlighting a severe liquidity and market confidence crisis in the solar and consumer goods sectors. SunPower has a 180-day cure period until January 19, 2027, and may seek an additional 180-day extension by moving to the Nasdaq Capital Market, but faces delisting if unable to cure. Purple Innovation received a Hearings Panel decision granting continued listing subject to demonstrating compliance by July 31, 2026, and executed a 1-for-25 reverse stock split effective July 20, 2026, which brought its stock price to $7.12 per share. The period-over-period data shows no revenue or margin trends available, but the insider activity and capital allocation data are absent, suggesting management may be avoiding signaling. The most critical development is the imminent compliance deadline for Purple Innovation (July 31, 2026), which creates a binary event for its listing status. Portfolio-level patterns indicate that both companies are in distressed situations with high delisting risk, and the market should monitor for potential reverse stock splits or further regulatory actions.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — July 22, 2026

The 32 filings reveal a high volume of routine board and C-suite transitions, with 15 officer/director departures and 13 appointments, mostly amicable and planned. Notable CEO successions include Jackson Financial, FirstCash Holdings, Toro, and American Healthcare REIT, signaling orderly leadership refresh. Two filings stand out for financial performance: RPM International reported record sales but mixed earnings with Consumer Group weakness, while FirstCommunity Corp posted strong net income growth (+46.5% YoY) but saw deposit and credit quality softening. A key risk is Red Cat Holdings' for-cause CRO termination and ensuing litigation, which could distract management. Sector themes include a wave of CFO/CAO changes (Keros, Shenandoah, NewHold, Jackson) and board additions with deep industry expertise (Guidewire, Target, AXT, Prairie). Overall, the stream is dominated by neutral, low-materiality events, but the few financial disclosures and leadership changes offer selective investment signals.

32 high priority 32 total filings
· daily

USA Insider Trading Pulse — July 22, 2026

Today's insider trading pulse reveals a clear divergence between executive selling and buying, with notable insider sales at Sea Ltd, Sagimet Biosciences, and NewAmsterdam Pharma, while CEO purchases at 17 Education & Technology Group and Sterling Real Estate Trust signal management confidence. The most significant insider sale is the $19M block trade by Franklin Resources in Clarion Partners Real Estate Income Fund, while the most material insider purchase is the $1.46M acquisition by Sterling Real Estate Trust's CEO. A cluster of negative sentiment surrounds biotech and tech names, with multiple insiders selling under 10b5-1 plans, suggesting pre-planned diversification rather than panic. On the positive side, insider buying at 17 Education, TSMC, and Hudson Technologies indicates selective conviction in undervalued names. The day's activity is dominated by equity awards and deferred compensation grants, which are neutral signals, but the raw selling volume far exceeds buying volume in dollar terms, creating a cautious near-term backdrop for the broader market.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — July 22, 2026

The July 22, 2026 M&A digest captures a bifurcated market: large-scale, accretive consolidations in real estate and consumer staples, alongside SPACs racing against the clock. The most material developments are the completion of Columbia Financial's acquisition of Northfield Bancorp (NFBK) and Public Storage's transformative deal for National Storage Affiliates Trust (NSA), which adds over 1,000 properties and immediate FFO accretion. Vita Coco's $175M acquisition of Copra signals strategic bolt-on M&A in premium beverage, while Nth Cycle's de-SPAC with Kensington Capital ($585M enterprise value) highlights appetite for critical minerals. However, two of three tracked SPACs (Black Hawk, Hudson) have extended their deadlines for the second time, indicating persistent deal-finding difficulties. Insider and financial data are sparse across these filings, limiting conviction signals. Key forward-looking catalysts include Nth Cycle's Q4 2026 de-SPAC close and Vita Coco's 2029 earnout, while the wave of SPAC extensions creates a risk of liquidations if deadlines are not met.

11 high priority 11 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 22, 2026

Overnight SEC filings reveal a market bifurcated between strong operational performance in select industrial and commodity sectors and significant headwinds in consumer staples, airlines, and technology. Cal-Maine Foods' 49.9% YoY revenue decline and net loss highlight a severe egg industry oversupply, while Southern Copper's record 40.6% revenue growth and 71.6% net income surge underscore a commodity super-cycle. Insider selling is pronounced, with United Airlines' CEO selling $18.8M in stock and multiple director-level sales at Western Digital and Kaspi.kz, signaling management caution. Conversely, SK hynix's $5.1B AI memory investment and monday.com's strategic restructuring (20% workforce cut) point to aggressive positioning for AI-driven growth. Capital allocation trends are mixed: Cal-Maine repurchased $30.1M in shares despite losses, while Banco Santander's record H1 profit was offset by rising provisions. Portfolio-level patterns show a clear divergence between commodity producers (copper, iron ore) benefiting from price inflation and consumer-facing companies (eggs, airlines) facing demand normalization. The most critical development is the Braskem debt restructuring impasse, where holders proposed ~R$50B in terms deemed 'far from acceptable,' posing a systemic risk to Brazilian credit markets.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — July 21, 2026

The sole filing from CrowdStrike Holdings, Inc. within the S&P 500 Technology sector reveals a notable insider selling event by the company's President and CEO, George Kurtz. While the total transaction value of ~$509K is moderate relative to his substantial holdings of over 8 million shares, the sale was executed under a pre-arranged 10b5-1 plan, which somewhat mitigates concerns about negative sentiment. The filing does not contain period-over-period financial comparisons, forward-looking guidance, or capital allocation data, limiting the ability to derive broader sector trends or portfolio-level patterns. The key takeaway is that this insider activity, though planned, warrants monitoring for any acceleration in selling or changes in management's public commentary. No other S&P 500 Technology filings were available for this period, preventing cross-company synthesis or theme identification.

1 high priority 1 total filings
· daily

Nasdaq 100 Stocks SEC Filings — July 21, 2026

Intuitive Surgical's Q2 2026 10-Q reveals a company firing on all cylinders, with total revenue surging 18.5% YoY to $2.89B and net income jumping 24.3% to $818.1M, driven by a 150 bps expansion in gross margins to 67.8%. The standout signal is the massive $1.44B in share repurchases during H1 2026, a 7x increase from the prior year, signaling extreme management confidence and a strong commitment to shareholder returns. However, this aggressive buyback has drained cash reserves, with cash and equivalents falling 18% from year-end 2025 to $2.76B, a key risk to monitor. Operating leverage is evident as income from operations grew 30.7% YoY, outpacing revenue growth, while operating expenses rose a more modest 13.0%. The absence of insider trading data or forward guidance in this filing limits visibility into management's near-term outlook, but the robust operational and capital allocation trends paint a bullish picture for this robotics leader.

1 high priority 1 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — July 21, 2026

The 29 filings for July 21, 2026, reveal a landscape dominated by corporate control events and significant insider ownership adjustments. The most material developments are the take-private of KORE Group Holdings at $9.25/share and the announced acquisition of Personalis by Tempus AI, both high-certainty catalysts. A notable cluster of insider activity is seen at ZeroStack Corp. (formerly Flora Growth), where three insiders—including the CEO—collectively control over 70% of shares and are incentivized by aggressive performance-based options tied to VWAP targets up to $17.85, a 250% premium to the exercise price. Passive institutional investors like Millennium Management and Royce & Associates are making measured, diversified bets, while a few filers (e.g., Dror Sherman at iPower) show rapid, opportunistic trading. The data suggests a bifurcated market: high-conviction insider moves in small/mid-cap names versus passive accumulation in larger, liquid names. No sector-wide margin or revenue trends are discernible from this set of filings, as they are primarily ownership disclosures rather than operating reports.

12 high priority 17 medium 29 total filings
· daily

S&P 500 Financials Sector SEC Filings — July 21, 2026

The S&P 500 Financials sector shows a bifurcated landscape in Q2 2026: property & casualty insurers (Chubb) and brokerages (Interactive Brokers) delivered strong core operating results with double-digit EPS growth, while diversified financial services firms (Marsh & McLennan) face margin compression and slowing underlying revenue growth. Capital One staged a dramatic turnaround from a year-ago loss to $3.0B net income, driven by a $662M loan reserve release and lower provisions. The sector is seeing significant debt capital markets activity, with Goldman Sachs and PNC collectively issuing $12B in senior notes, signaling opportunistic liability management and potential capital return capacity. Insider trading activity is notably absent across all filings, which is neutral but warrants monitoring. Key themes include: strong investment income tailwinds for insurers, credit normalization for consumer lenders, and a shift toward shareholder returns via buybacks (Marsh & McLennan H1 buybacks surged 152% YoY to $1.5B). The mixed sentiment across filings suggests selective positioning rather than broad sector conviction.

1 high priority 7 medium 8 total filings
· daily

S&P 500 Industrials Sector SEC Filings — July 21, 2026

The S&P 500 Industrials stream for July 21, 2026, reveals a sector bifurcated between operational strength and strategic transformation costs. 3M and Northrop Grumman both reported solid top-line growth (2.4% and 5.1% YoY, respectively) but experienced significant operating income compression due to large, one-time charges (divestitures, litigation, and contract adjustments), creating a 'mixed' sentiment profile. A key portfolio-level trend is the divergence between GAAP and adjusted metrics, with adjusted figures showing healthy margin expansion (3M +40 bps) while GAAP margins contracted sharply (3M -290 bps, Northrop -120 bps). The most critical development is the structural reshaping of FedEx, which completed the spin-off of FedEx Freight and changed its fiscal year, providing recast financials that show a strong 39.2% operating income growth in its core business. Insider activity was concentrated in Paychex, with a CFO sale and a director gift, but no pattern of concern emerges. The sector's forward-looking data is positive, with both 3M and Northrop Grumman raising full-year guidance, signaling management confidence in underlying business momentum despite near-term earnings noise.

6 high priority 3 medium 9 total filings
· daily

US Material Events SEC 8-K Filings — July 21, 2026

This digest covers 50 filings from July 21, 2026, revealing a market dominated by capital structure maneuvers, SPAC activity, and leadership transitions. The most significant themes are a wave of SPAC IPOs and business combination failures (FACT II, Twenty One Capital pivot), aggressive M&A in the consumer and defense sectors (Starco Brands, Innovative Aerosystems), and a notable number of distressed situations (Vicarious Surgical liquidation, Splash Beverage cash crunch). Period-over-period data was sparse in these event-driven filings, but where available, it showed strong performance (First Financial Bancorp record EPS up 8% YoY) alongside clear warning signs (Splash Beverage missed payments). Insider activity was limited, but the resignation of a director over a D&O insurance lapse at ClimateRock is a significant governance red flag. The overall sentiment is mixed, with a clear bifurcation between companies executing strategic growth and those facing existential challenges.

50 high priority 50 total filings
· daily

Insider Trading Pulse — July 21, 2026

The July 21, 2026 insider trading pulse reveals a day dominated by large-scale dispositions to the issuer at Cross Country Healthcare, where four top executives and directors collectively tendered over 886,000 shares at $13.25, signaling a potential capital return event or restructuring. Concurrently, a $44.9M disposition by ABRY Partners at KORE Group Holdings suggests a major PE exit. On the bearish side, notable open-market sales by the CTO of JFrog ($1.98M) and a 10% owner at Worthington Enterprises ($3.34M) raise caution flags. Positive signals are limited but include a director purchase at Wilson Bank Holding ($150K) and a TSMC VP buying $215K worth of shares. The day also saw significant equity awards at OSI Systems ($800K aggregate to four directors) and Imunon, alongside routine option exercises and RSU vestings. The overall sentiment is mixed, with a clear skew toward neutral events (gifts, awards, dispositions to issuer) but with several high-materiality bearish sales that warrant attention.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — July 21, 2026

The four Dow 30 filings for July 21, 2026, present a mixed picture of corporate health. 3M's Q2 results show a clear divergence between GAAP and adjusted performance: GAAP operating margins collapsed 290 bps YoY due to $619 million in special items (divestitures, litigation, restructuring), while adjusted margins improved 40 bps and adjusted EPS rose 11%. This gap, combined with a $2.99 billion treasury stock buyback that drained cash by 44%, signals aggressive capital return despite operational noise. Goldman Sachs issued $10 billion in long-term debt across three tranches (5.240%-6.215% coupons), a significant capital markets activity that suggests either opportunistic prefunding or balance sheet repositioning. Johnson & Johnson's insider sale of $5.79 million by an EVP, representing nearly 100% of her holdings after exercise, is a bearish signal from a senior executive. The key portfolio-level theme is capital allocation divergence: 3M is aggressively buying back stock while Goldman is issuing debt, and J&J insiders are selling. The most critical development is 3M's raised full-year adjusted EPS guidance to $8.80-$8.95, which, if achieved, would imply a forward P/E of ~17x based on current prices—a potential value opportunity if the adjusted earnings quality holds.

2 high priority 2 medium 4 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — July 21, 2026

The three filings in this digest all involve Nasdaq compliance issues, signaling a cluster of corporate distress among small-cap issuers. Origin Investment Corp I quickly resolved a technical audit committee deficiency, while Cypherpunk Technologies faces a more serious bid price deficiency with a 180-day cure period and potential reverse split. CN Healthy Food Tech Group Corp. received a delisting determination linked to CSRC review status, representing the highest materiality risk with an appeal deadline of July 23, 2026. No period-over-period comparisons, insider activity, or capital allocation data were available in these filings, limiting trend analysis. The overarching theme is regulatory and listing standard pressures, with CN Healthy Food Tech facing the most existential threat. Investors should monitor the appeal outcome and Cypherpunk's ability to regain compliance within the cure period.

3 high priority 3 total filings
· daily

Global High-Priority Regulatory Events — July 21, 2026

The July 21, 2026 filings reveal a day of extreme corporate distress and strategic realignment, dominated by a wave of insolvencies and liquidations. The most critical development is the liquidation of **Vicarious Surgical Inc.**, where stockholders are expected to receive nothing, and the Nasdaq delisting of **CN Healthy Food Tech Group Corp.**, which faces an existential appeal deadline. A significant cluster of three filings from **Simbhaoli Sugars Limited** shows its CIRP process finally moving forward after a stay was vacated, but the company remains deeply distressed with over ₹1.08 Cr in admitted claims. On the M&A front, **Gabriel India's** $98.44M acquisition of a 30% stake in HL Klemove India stands out as a high-growth bet on autonomous driving, while the **Bliss GVS Pharma** open offer at ₹299/share creates a potential arbitrage opportunity. The SPAC sector is active but troubled, with **FACT II Acquisition Corp.** terminating its deal and several others (Aeon, Horizon) taking on debt to fund searches. Period-over-period data from **MPS Limited** shows a strong 42.5% YoY net profit surge, while **Northpointe Bancshares** shows margin compression. The day's filings paint a picture of a market bifurcated between aggressive capital deployment for growth and the final throes of insolvency.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — July 21, 2026

Today's filings reveal a mixed picture with several high-profile SPAC transactions and corporate actions driving activity. Key themes include a significant SPAC merger valuing Terra Quantum at $3.5B, a contested tender offer for Lisata Therapeutics with financing issues, and a proxy fight at XAI Octagon over sub-adviser underperformance. Financial sector filings show mixed results: Synchrony Financial reported record purchase volume (+8% YoY) but earnings declined 8% due to higher provisions, while Cementos Pacasmayo posted strong EBITDA growth (+34.3% YoY) but margin contraction in cement. Insider activity was limited, with notable insider selling at KB Financial Group (largest shareholder reduced stake). Capital allocation trends include Energy Transfer's $1.75B debt issuance and Novo Nordisk's ongoing buyback. Several routine foreign issuer filings provided minimal new information.

10 high priority 40 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — July 21, 2026

All four filings originate from General Motors and its captive finance arm, GM Financial, making this a single-company deep dive rather than a broad sector overview. The overarching theme is a tale of two narratives: GM's operational strength (record EBIT-adjusted margins, raised full-year guidance, robust buyback activity) versus mounting credit stress in its financing unit (rising delinquencies, higher loan loss provisions, declining net income). Period-over-period comparisons reveal a 1.9% YoY revenue growth at the parent level, but net income attributable to stockholders plunged 31.1% YoY due to higher adjustments and tax expenses. GM Financial's net income fell 15-16% YoY, with the allowance for loan losses increasing 5.2% since year-end 2025, signaling deteriorating credit quality. The most critical development is the divergence between GM's raised EBIT-adjusted guidance ($14-16B) and the weakening consumer credit picture at GM Financial, which could pressure future earnings. No insider trading activity was reported in any filing, removing a key sentiment gauge. The portfolio-level pattern is a classic 'auto cycle tension' between strong manufacturing margins and rising consumer credit risk.

2 high priority 2 medium 4 total filings